Table 1.

Clinical and laboratory characteristics in patients with essential thrombocythemia, according to pattern of c-mplexpression

CharacteristicAll patients, n = 88Pattern of c-mpl expressionP
Uniform; n = 28, 32% of allHeterogeneous-moderate; n = 30,
34% of all
Heterogeneous-weak; n = 30, 34% of all
Sex: M/F (ratio) 39/49  (0.79) 11/17  (0.64) 15/15  (1.00) 13/17  (0.76) .691  
Median age, y (range) 53  (16-84) 53  (22-80) 56  (19-84) 48  (16-77) .405  
Median Hb, g/L (range) 13.9  (102-186) 139  (102-175) 136  (112-186) 140  (108-164) .928  
Median Hct (range) 0.42  (0.3-0.55) 0.42  (0.3-0.52) 0.41  (0.32-0.55) 0.42  (0.37-0.48) .954  
Median PLT count, 109/L (range) 775  (350-1673)* 747  (505-1415) 780  (601-1673) 793  (350-1600)* .212  
Median WBC count, 109/L (range) 8.5  (4.8-28.8) 7.7  (4.8-12.0) 8.6  (5.1-16.8) 8.9  (5.5-28.8) .045  
No. BM hypercellularity (%) 56  (64) 13  (46) 23  (77) 20  (67) .052  
No. with splenomegaly (%) 25  (28) 5  (18) 13  (43) 7  (23) .074  
No. with thrombosis (%) 20  (23) 2  (7) 5  (17) 13  (43) .020 
CharacteristicAll patients, n = 88Pattern of c-mpl expressionP
Uniform; n = 28, 32% of allHeterogeneous-moderate; n = 30,
34% of all
Heterogeneous-weak; n = 30, 34% of all
Sex: M/F (ratio) 39/49  (0.79) 11/17  (0.64) 15/15  (1.00) 13/17  (0.76) .691  
Median age, y (range) 53  (16-84) 53  (22-80) 56  (19-84) 48  (16-77) .405  
Median Hb, g/L (range) 13.9  (102-186) 139  (102-175) 136  (112-186) 140  (108-164) .928  
Median Hct (range) 0.42  (0.3-0.55) 0.42  (0.3-0.52) 0.41  (0.32-0.55) 0.42  (0.37-0.48) .954  
Median PLT count, 109/L (range) 775  (350-1673)* 747  (505-1415) 780  (601-1673) 793  (350-1600)* .212  
Median WBC count, 109/L (range) 8.5  (4.8-28.8) 7.7  (4.8-12.0) 8.6  (5.1-16.8) 8.9  (5.5-28.8) .045  
No. BM hypercellularity (%) 56  (64) 13  (46) 23  (77) 20  (67) .052  
No. with splenomegaly (%) 25  (28) 5  (18) 13  (43) 7  (23) .074  
No. with thrombosis (%) 20  (23) 2  (7) 5  (17) 13  (43) .020 

Hb indicates hemoglobin; Hct, hematocrit; PLT, platelet; WBC, white blood cell; and BM, bone marrow.

*

The low limit of the range represents the results in the patient with latent chronic myeloproliferative disease.

The spleen size was evaluated with use of ultrasonography.

Close Modal

or Create an Account

Close Modal
Close Modal